Day: April 28, 2021

Cardiovascular diseases are responsible for 17.9 million deaths every year¹, a third of all deaths globally² Roche announces five new intended uses for key cardiac biomarkers to help identify cardiovascular risk, better diagnose patients and support early treatment Early diagnosis and treatment can contribute to saving or improving people’s lives and could help healthcare systems save moneyBasel, 28 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced a series of five new intended uses for two key cardiac biomarkers using the Elecsys® technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers³ have proven to be successful in supporting cardiovascular disease management and can help clinicians diagnose heart attacks⁴ (cTnT-hs)...

Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium – April 28th, 2021, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: www.melexis.com/en/news/2021/financial/melexis-q1-2021-results AttachmentPR_ENG_Melexis_Q1 2021

Gereglementeerde informatie  Tussentijdse verklaring, opgesteld door de Raad van BestuurIeper, België – 28 april 2021, 07.00 uur CET Geachte, hieronder vindt u de link naar ons meest recente persbericht: www.melexis.com/nl/news/2021/financial/melexis-q1-2021-results BijlagePR_NL_Melexis_Q1 2021

Information réglementée Déclaration intermédiaire par le Conseil d’administrationYpres, Belgique – le 28 avril 2021, 07.00 H. CET Veuillez trouver ici le lien vers notre dernier communiqué de presse: www.melexis.com/fr/news/2021/financial/melexis-q1-2021-results Pièce jointePR_FR_Melexis_Q1 2021

Borregaard’s operating revenues reached NOK 1,419 million (NOK 1,372 million)² in the 1st quarter of 2021. EBITDA¹ increased to NOK 302 million (NOK 242 million). All business areas improved their results compared with the corresponding quarter in 2020. The net currency impact on EBITDA¹ was negative compared with the 1st quarter of 2020. EBITDA¹ in BioSolutions improved as a result of price increases for certain biopolymer applications and reduced costs. The BioMaterials result improved due to high deliveries of speciality cellulose and a favourable product mix which more than compensated for lower sales prices. In Fine Chemicals, the effect of low deliveries was more than offset by a favourable product mix for fine chemical intermediates and a high production volume of bioethanol. Profit before tax was NOK 176 million (NOK 111 million)....

Norwegian Finans Holding (the NFH Group) reported profit after tax in the first quarter of 2021 of NOK 396.8 million, compared with NOK 436.2 million in the fourth quarter of 2020 and MNOK 368.0 in the first quarter last year. The decrease from the previous quarter is mainly caused by lower interest income due to volume and currency effects, and VISA dividend received in the fourth quarter, partly offset by seasonal provision income from kick-back in the current quarter. Return on equity was 14.3%, compared with 16.4% in the previous quarter. The return on assets was 2.6%, compared with 2.7% in the previous quarter. A dividend of NOK 6 per share was approved at the Annual General Meeting (AGM) on April 27th, with NOK 5 per share to be paid on May 6 and the Board of Directors has been granted authorization to pay the remaining NOK 1 per...

Press Release April 28, 2021 – N° 10 First quarter 2021 results SCOR demonstrates its shock-absorbing capacityonce again in Q1 2021 In Q1 2021, SCOR’s financial results have been impacted by the unique combination of known and modelled Covid-19 claims development and a series of large natural catastrophes, driven by a polar vortex causing Texas Winter Storm Uri. Covid-19 claims are manageable, developing as expected and tracking closely in line with what was previously communicated1. In Q1 2021, Covid-19 impact stands on the Life side at EUR 162 million2, of which EUR 145 million comes from the U.S. mortality portfolio, and overall has been stable on the P&C side since December 31, 2020. The SCOR group continues to grow and to absorb shocks. SCOR records a net income of EUR 45 million in Q1 2021 and delivers a very high solvency...

Communiqué de presse 28 avril 2021 – N° 10 Résultats du premier trimestre 2021 Au premier trimestre 2021, SCOR démontre une nouvelle fois sa capacité à absorber les chocs Au premier trimestre 2021, les résultats financiers de SCOR ont subi l’effet de la conjonction inédite de la sinistralité liée à la pandémie de Covid-19 dont les effets sont connus et modélisés, et d’une série de catastrophes naturelles de grande ampleur, au premier rang desquelles la tempête hivernale Uri, au Texas, déclenchée par un vortex polaire. Les sinistres liés à la pandémie de Covid-19 restent sous contrôle. Ils se développent conformément aux prévisions ce que SCOR a déjà communiquées1. Au premier trimestre 2021, l’impact de la Covid-19 s’élève à EUR 162 millions2 pour l’activité de réassurance vie, dont EUR 145 millions issus du portefeuille de mortalité...

Dassault Systèmes Reports 2021 First Quarter ResultsAbove the High End of Company Guidance VÉLIZY-VILLACOUBLAY, France — April 28, 2021 — Dassault Systèmes (Euronext Paris: #13065, DSY.PA) announces IFRS unaudited financial results for the first quarter ended March 31, 2021. The Group’s Board of Directors reviewed these results on April 27, 2021. This press release also includes financial information on a non-IFRS basis and reconciliations with IFRS figures in the Appendix to this communication. First Quarter Highlights and Financial Summary(Unaudited, revenue growth in constant currencies, EPS presented on a diluted basis)IFRS EPS of €0.66, up 54% and non-IFRS EPS of €1.14, up 20%, 28% in constant currencies On an organic basis, non-IFRS software revenue up 10% Non-IFRS licenses and other software revenue up 25%, on upside principally...

Dassault Systèmes annonce des résultats du 1ertrimestre 2021au-dessus de la fourchette haute de ses objectifs VÉLIZY-VILLACOUBLAY, France — 28 avril 2021 — Dassault Systèmes (Euronext Paris : #13065, DSY.PA), publie ses résultats financiers non audités en normes IFRS pour le 1er trimestre clos le 31 mars 2021. Ces résultats ont été revus par le Conseil d’administration le 27 avril 2021. Ce communiqué comporte également une information financière exprimée en normes non-IFRS, pour laquelle un tableau de réconciliation avec les données IFRS figure en annexe. Faits marquants et résultats financiers du 1ertrimestre 2021(données non auditées et croissance du chiffre d’affaires à taux de change constants)BNPA IFRS à 0,66 euro, en croissance de 54% et BNPA non-IFRS à 1,14 euro, en hausse de 20%, 28% à taux de change constants Croissance organique...